Report Detail
Global Artificial Blood Substitute Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4668228 |
- 22 January, 2026 |
- Global |
- 89 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Artificial Blood Substitute market size was valued at US$ 12.74 million in 2025 and is forecast to a readjusted size of US$ 59.14 million by 2032 with a CAGR of 24.8% during review period.
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
The market for artificial blood substitutes is primarily driven by increasing medical demand and advancements in technology. On a global scale, the demand for blood transfusions continues to rise, while the availability of suitable blood is often constrained by challenges such as blood type compatibility, limited shelf life, and underdeveloped blood supply systems. Artificial blood substitutes can play a vital role in emergency care, mass casualty incidents, and battlefield medicine. In addition, the accelerating aging population, along with the growing number of major surgeries and trauma cases, has created strong clinical demand for safe, long-lasting, and universally compatible alternatives. Advances in bioengineering, nanotechnology, and synthetic biology are also fostering the development of more efficient and stable products. Furthermore, concerns over transfusion-related infections and low blood donation rates in certain regions are encouraging healthcare systems to prioritize artificial blood solutions, collectively driving market growth.
This report is a detailed and comprehensive analysis for global Artificial Blood Substitute market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Blood Substitute market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Blood Substitute market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Blood Substitute market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Blood Substitute market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Blood Substitute
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Blood Substitute market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurum Biosciences Ltd., Hemarina, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma, Safi Biotherapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Blood Substitute market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Market segment by Application
Military
Civil
Market segment by players, this report covers
Aurum Biosciences Ltd.
Hemarina
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Safi Biotherapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Blood Substitute product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Blood Substitute, with revenue, gross margin, and global market share of Artificial Blood Substitute from 2021 to 2026.
Chapter 3, the Artificial Blood Substitute competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Blood Substitute market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Blood Substitute.
Chapter 13, to describe Artificial Blood Substitute research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Artificial Blood Substitute by Type
- 1.3.1 Overview: Global Artificial Blood Substitute Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Artificial Blood Substitute Consumption Value Market Share by Type in 2025
- 1.3.3 Perfluorocarbon-based Oxygen Carrier (PFBOC)
- 1.3.4 Hemoglobin-based Oxygen Carrier (HBOC)
- 1.4 Global Artificial Blood Substitute Market by Application
- 1.4.1 Overview: Global Artificial Blood Substitute Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Military
- 1.4.3 Civil
- 1.5 Global Artificial Blood Substitute Market Size & Forecast
- 1.6 Global Artificial Blood Substitute Market Size and Forecast by Region
- 1.6.1 Global Artificial Blood Substitute Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Artificial Blood Substitute Market Size by Region, (2021-2032)
- 1.6.3 North America Artificial Blood Substitute Market Size and Prospect (2021-2032)
- 1.6.4 Europe Artificial Blood Substitute Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Artificial Blood Substitute Market Size and Prospect (2021-2032)
- 1.6.6 South America Artificial Blood Substitute Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Artificial Blood Substitute Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Aurum Biosciences Ltd.
- 2.1.1 Aurum Biosciences Ltd. Details
- 2.1.2 Aurum Biosciences Ltd. Major Business
- 2.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Product and Solutions
- 2.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Aurum Biosciences Ltd. Recent Developments and Future Plans
- 2.2 Hemarina
- 2.2.1 Hemarina Details
- 2.2.2 Hemarina Major Business
- 2.2.3 Hemarina Artificial Blood Substitute Product and Solutions
- 2.2.4 Hemarina Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Hemarina Recent Developments and Future Plans
- 2.3 HbO2 Therapeutics
- 2.3.1 HbO2 Therapeutics Details
- 2.3.2 HbO2 Therapeutics Major Business
- 2.3.3 HbO2 Therapeutics Artificial Blood Substitute Product and Solutions
- 2.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 HbO2 Therapeutics Recent Developments and Future Plans
- 2.4 KaloCyte Inc.
- 2.4.1 KaloCyte Inc. Details
- 2.4.2 KaloCyte Inc. Major Business
- 2.4.3 KaloCyte Inc. Artificial Blood Substitute Product and Solutions
- 2.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 KaloCyte Inc. Recent Developments and Future Plans
- 2.5 SpheriTech Ltd.
- 2.5.1 SpheriTech Ltd. Details
- 2.5.2 SpheriTech Ltd. Major Business
- 2.5.3 SpheriTech Ltd. Artificial Blood Substitute Product and Solutions
- 2.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 SpheriTech Ltd. Recent Developments and Future Plans
- 2.6 NuvOx Pharma
- 2.6.1 NuvOx Pharma Details
- 2.6.2 NuvOx Pharma Major Business
- 2.6.3 NuvOx Pharma Artificial Blood Substitute Product and Solutions
- 2.6.4 NuvOx Pharma Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 NuvOx Pharma Recent Developments and Future Plans
- 2.7 Safi Biotherapeutics
- 2.7.1 Safi Biotherapeutics Details
- 2.7.2 Safi Biotherapeutics Major Business
- 2.7.3 Safi Biotherapeutics Artificial Blood Substitute Product and Solutions
- 2.7.4 Safi Biotherapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Safi Biotherapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Artificial Blood Substitute Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Artificial Blood Substitute by Company Revenue
- 3.2.2 Top 3 Artificial Blood Substitute Players Market Share in 2025
- 3.2.3 Top 6 Artificial Blood Substitute Players Market Share in 2025
- 3.3 Artificial Blood Substitute Market: Overall Company Footprint Analysis
- 3.3.1 Artificial Blood Substitute Market: Region Footprint
- 3.3.2 Artificial Blood Substitute Market: Company Product Type Footprint
- 3.3.3 Artificial Blood Substitute Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Artificial Blood Substitute Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Artificial Blood Substitute Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Artificial Blood Substitute Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Artificial Blood Substitute Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Artificial Blood Substitute Consumption Value by Type (2021-2032)
- 6.2 North America Artificial Blood Substitute Market Size by Application (2021-2032)
- 6.3 North America Artificial Blood Substitute Market Size by Country
- 6.3.1 North America Artificial Blood Substitute Consumption Value by Country (2021-2032)
- 6.3.2 United States Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 6.3.3 Canada Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Artificial Blood Substitute Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Artificial Blood Substitute Consumption Value by Type (2021-2032)
- 7.2 Europe Artificial Blood Substitute Consumption Value by Application (2021-2032)
- 7.3 Europe Artificial Blood Substitute Market Size by Country
- 7.3.1 Europe Artificial Blood Substitute Consumption Value by Country (2021-2032)
- 7.3.2 Germany Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 7.3.3 France Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 7.3.5 Russia Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 7.3.6 Italy Artificial Blood Substitute Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Artificial Blood Substitute Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Artificial Blood Substitute Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Artificial Blood Substitute Market Size by Region
- 8.3.1 Asia-Pacific Artificial Blood Substitute Consumption Value by Region (2021-2032)
- 8.3.2 China Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 8.3.3 Japan Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 8.3.5 India Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 8.3.7 Australia Artificial Blood Substitute Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Artificial Blood Substitute Consumption Value by Type (2021-2032)
- 9.2 South America Artificial Blood Substitute Consumption Value by Application (2021-2032)
- 9.3 South America Artificial Blood Substitute Market Size by Country
- 9.3.1 South America Artificial Blood Substitute Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Artificial Blood Substitute Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Artificial Blood Substitute Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Artificial Blood Substitute Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Artificial Blood Substitute Market Size by Country
- 10.3.1 Middle East & Africa Artificial Blood Substitute Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Artificial Blood Substitute Market Size and Forecast (2021-2032)
- 10.3.4 UAE Artificial Blood Substitute Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Artificial Blood Substitute Market Drivers
- 11.2 Artificial Blood Substitute Market Restraints
- 11.3 Artificial Blood Substitute Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Artificial Blood Substitute Industry Chain
- 12.2 Artificial Blood Substitute Upstream Analysis
- 12.3 Artificial Blood Substitute Midstream Analysis
- 12.4 Artificial Blood Substitute Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Artificial Blood Substitute. Industry analysis & Market Report on Artificial Blood Substitute is a syndicated market report, published as Global Artificial Blood Substitute Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Artificial Blood Substitute market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
